Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ZEVRA-THERAPEUTICS-INC-117033343/news/Zevra-Therapeutics-Receives-FDA-Acceptance-of-Resubmission-of-NDA-for-Arimoclomol-as-a-Treatment-for-45691506/?utm_source=whatsapp&utm_medium=social&utm_campaign=share